Source author record

Pierre-Yves Brillet

Pierre-Yves Brillet appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
5topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

DiffSegLung: Diffusion Radiomic Distillation for Unsupervised Lung Pathology Segmentation

Unsupervised segmentation of pulmonary pathologies in CT remains an open challenge due to the absence of annotated multi pathology cohorts and the failure of existing diffusion-based methods to exploit the quantitative Hounsfield Unit (HU) signal that physically distinguishes tissue classes. To address this, we propose DiffSegLung,a framework that introduces Diffusion Radiomic Distillation, in which handcrafted radiomic descriptors serve as a physics grounded teacher to shape the bottleneck of a 3D diffusion U-Net via a contrastive objective, transferring pathology discriminative structure into the learned representation without any annotations. At inference, the teacher is discarded and multitimestep bottleneck features are clustered by a Gaussian Mixture Model with HU-guided label assignment, followed by Sobel Diffusion Fusion for boundary refinement. Evaluated on 190 expert annotated axial slices drawn from four heterogeneous CT cohorts, Diff-SegLung improves segmentation across all four pathology classes over unsupervised baselines and improves generation fidelity over prior CT diffusion models.

preprint2020arXiv

AI-Driven CT-based quantification, staging and short-term outcome prediction of COVID-19 pneumonia

Chest computed tomography (CT) is widely used for the management of Coronavirus disease 2019 (COVID-19) pneumonia because of its availability and rapidity. The standard of reference for confirming COVID-19 relies on microbiological tests but these tests might not be available in an emergency setting and their results are not immediately available, contrary to CT. In addition to its role for early diagnosis, CT has a prognostic role by allowing visually evaluating the extent of COVID-19 lung abnormalities. The objective of this study is to address prediction of short-term outcomes, especially need for mechanical ventilation. In this multi-centric study, we propose an end-to-end artificial intelligence solution for automatic quantification and prognosis assessment by combining automatic CT delineation of lung disease meeting performance of experts and data-driven identification of biomarkers for its prognosis. AI-driven combination of variables with CT-based biomarkers offers perspectives for optimal patient management given the shortage of intensive care beds and ventilators.